key: cord-1011751-9vxcdy5p
authors: Simon, Miriam; Veit, Michael; Osterrieder, Klaus; Gradzielski, Michael
title: “Surfactants - compounds for inactivation of SARS-CoV-2 and other enveloped viruses“
date: 2021-06-12
journal: Curr Opin Colloid Interface Sci
DOI: 10.1016/j.cocis.2021.101479
sha: 33dd7b8cd2e22c684617b08af81133dbd21f042e
doc_id: 1011751
cord_uid: 9vxcdy5p

We provide here a general view on the interactions of surfactants with viruses, with a particular emphasis on how such interactions can be controlled and employed, for inhibiting the infectivity of enveloped viruses, including coronaviruses. The aim is to provide to interested scientists from different fields, including chemistry, physics, biochemistry, and medicine, an overview over the basic properties of surfactants and (corona)viruses, which are relevant to understanding the interactions between the two. Various types of interactions between surfactant and virus are important, and they act on different components of a virus such as the lipid envelope, membrane (envelope) proteins and nucleo-capsid proteins. Accordingly, this cannot be a detailed account of all relevant aspects, but instead a summary that bridges between the different disciplines. We describe concepts and cover a selection of the relevant literature as an incentive for diving deeper into the relevant material. Our focus is on more recent developments around the COVID-19 pandemic caused by SARS-CoV-2, applications of surfactants against the virus, and on the potential future use of surfactants for pandemic relief. However, we also cover the most important aspects of the historical development of using surfactants in combatting virus infections. We conclude that surfactants are already playing very important roles in various directions of defence against viruses, either directly, as in disinfection, or as carrier components of drug delivery systems for prophylaxis or treatment. By designing tailor-made surfactants and, consequently, advanced formulations, one can expect a more and more effective use of surfactants, either directly as antiviral compounds or as part of more complex formulations.

to various organelles within a cell, which in turn affects the lipid composition of a virus envelope. Next, we will recall some basic facts and properties of surfactants that are relevant to their ability to interact with components of self-assembled colloids including viruses. In the next steps we then focus on surfactant interactions with model lipid membranes and different types of viral proteins separately, before reporting on recent work on the interaction of surfactants with real viruses. We do so with a focus on enveloped viruses, including SARS-CoV-2, with the aim of reducing or eliminating virus infectivity. Of course, for enveloped viruses the surfactant primarily interacts with the protein-studded lipid envelope This review combines the complex and comprehensive view from a virology perspective with the simplifying approach from the physics and physical chemistry angle. By doing so, our aim is to relate general physico-chemical principles to the actual behaviour of surfactants in a complex situation, which is the case if surfactants are mixed with viruses. This approach should deliver general guidelines for how to best apply surfactants in the context of inhibiting virus infectivity and broaden the view with respect to the aspects relevant in such undertakings.

As the focus of this review is on enveloped viruses we will first describe their distinctive feature, the lipid membrane that constitutes the envelope. It is central to the function of this group of viruses, and we will recall some of the basic properties of lipid membranes before describing in more detail their composition and properties in viruses, which is a central aspect to be considered in any approach aiming at disabling virus function by destroying membrane integrity. The lipid envelope is usually the most vulnerable part of a virus particle and, hence, enveloped viruses are easier to inactivate when compared with non-enveloped viruses.

Biological membranes are complex structures that consist of many different lipids interactions, while cellular proteins are largely excluded [18] .

Since both proteins and lipids are mobile within lipid membranes, the membrane-contacting region of a protein constantly interacts with various lipids. These interactions are highly dynamic; a boundary lipid molecule typically resides for less than 1 µs at the protein's surface before it is replaced by another lipid molecule. However, certain lipids bind with higher specificity to recognition motifs of a protein, in a manner consistent with a typical ligand or co-factor, which in turn can affect the activity of the protein bound. A prime example is cholesterol-binding to seven transmembrane receptors, which was discovered by crystallography and allowed identification of protein consensus motifs for cholesterol binding [19] . A similar binding site for cholesterol is present in the outer part of the transmembrane region of the hemagglutinin of some influenza virus strains [20] , of the glycoprotein of Ebola virus [21] and the spike glycoprotein (S) of SARS-CoV-2 [22] . The membrane proteins of Zika virus (and possibly other flaviviruses) contain two binding sites for a Y-shaped lipid [23] . In both viruses, mutagenesis of the amino acids involved in lipid-binding greatly reduced virus growth in cell culture [20] [21] [22] [23] . Furthermore, lipids may bind to regions of a protein that do not contact the membrane. Cryo-EM of the SARS-CoV-2 S revealed that its receptor-binding domains tightly bind the unsaturated fatty acid linoleic acid, an interaction that stabilizes a locked conformation, resulting in reduced binding to its receptor [24] . In addition, even non-enveloped viruses might contain lipids. For example, more than 220 lipid species could be extracted from purified iridoviruses that do not have an envelope, and identified by mass spectrometry [25] .

To endow a new virus particle with a lipid envelope, a flat membrane must be transformed into a hollow sphere, while the opposite shape change occurs during virus entry by membrane fusion. Thus, a force must act on the bilayer to cause curvature, which is provided by proteins that push or pull on the membrane. However, lipids also contribute to these shape alterations since individual lipids differ in intrinsic curvature. Most phospholipids have a cylindrical shape, i.e., the hydrophilic head group and the hydrophobic tail are about the same size and their side-by-side arrangement prefers to generate flat membranes. Some lipids, such as cholesterol, are cone-shaped, composed of a small head group and a large tail. Other lipids, J o u r n a l P r e -p r o o f for example lysophospholipids, are shaped like an inverted cone having a large head group and a small tail. Lipids with an intrinsic curvature positively or negatively affect certain stages of bud formation. Inverted cones present in the outer leaflet and cones in the inner leaflet facilitate a positive (outward facing) curvature of a flat membrane. Likewise, changes in curvature also occur during membrane fusion and certain lipids are known to facilitate or hamper this process [26] . Similarly, one can expect surfactants with their different spontaneous curvature to have such effects that suppress membrane fusion and/or virus budding.

It can be noted that the geometric effects just described for the packing and curving of lipid bilayers typically are described in surfactant science in a more quantitative fashion by the dimensionless packing parameter p that is defined as the ratio between the volume of the hydrophobic part of the amphiphile v a , by the product of the head group area a h (the area required by the molecule at the amphiphilic interface) and the stretched length L of the hydrophobic part, i.e., p = v a /(a h •L). [27] According to a simple geometric consideration one then will form spherical aggregates for: p < 1/3, cylindrical aggregates for: 1/3 < p <1/2, and bilayers for: 1/2 < p < 1.

The main lipid biosynthetic organelle is the endoplasmic reticulum (ER), which produces phospholipids, cholesterol and ceramide, the precursor for complex glycosphingolipids.

However, the ER displays only low concentrations of sterols since they are rapidly transported to the Golgi complex and to the plasma membrane. As a result, the molar ratio of cholesterol to phospholipids is only around 0.15 in the ER, but successively increases throughout the Golgi cisternae, and finally reaches values of 1.0 at the plasma membrane.

This distribution is consistent with the function of these organelles: insertion and transport of newly synthesized lipids and proteins in the ER, and resistance against mechanical stress of the plasma membrane. Minor differences exist also for the distribution of individual phospholipids along the membranes of the exocytotic pathway, i.e. phosphatidylserine (PS) increases and phosphatidylinositol (PI), phosphatidylethanolamine (PE) and phosphatidylcholine (PC) decrease. Likewise, the concentration of glycosphingolipids, which are synthesized from ceramide and then heterogeneously glycosylated in the Golgi complex, also increases along the exocytotic pathway. In polarized cells, they are exclusively J o u r n a l P r e -p r o o f transported to the apical membrane, which is separated by a diffusion barrier from the basolateral plasma membrane.

During intracellular transport, there is another reason why an uneven distribution of lipids builds up. Whereas all lipids are symmetrically distributed between the two leaflets of the ER bilayer, the Golgi and the plasma membranes display an asymmetric lipid distribution:

Glycolipids are exclusively present on the luminal side, whereas PE, PS and PI are enriched in the cytosolic leaflet. Once established, the asymmetric distribution of lipids is stable, flip-flop of individual molecules across the membrane occurs on the time scale of days [28, 29] , which is surprisingly slow for the movement across such a small distance.

A virus is a self-assembled system containing nucleic acid (RNA or DNA) and proteins, where positively charged proteins form a shell, the nucleocapsid, around the condensed RNA/DNA molecules [30] . Nucleocapsids can adopt an icosahedral or rod-like (helical) shape, and the latter exemplified by TMV (tobacco mosaic virus), and were one of the first important structures characterized by electron microscopy in the 1930's. In many cases, the basic structure is complemented by lipids that form an envelope around this basic assembly.

Accordingly, one distinguishes non-enveloped and enveloped viruses. Coronaviruses are RNA viruses belonging to the latter group with a typical spherical appearance, and the SARS-CoV-2 particle has a mean outer diameter of 91±11 nm ( Figure 1 ) [31] .

Most suited to gain detailed structural information regarding the mesoscopic structure of most viruses is cryo-electron microscopy (cryo-EM) [31] or cryo-electron tomography (cryo-ET) [32] , techniques that even allow deduction of structural details including those for the spike [33] . Cyro-EM and cryo-ET are particularly suited here as the vitrified film of an aqueous solution typically has a thickness of 100-300 nm and therefore is perfectly suited size-wise to host virus particles and study them.

Of course, a main site of surfactant interaction with coronaviruses (and this applies to any virus) are the proteins contained in the virus envelope.

The most frequently encountered protein in the coronavirus envelope is the M protein (1000-2000 molecules per particle [34] ) that has a short ectodomain, three transmembrane regions and a longer cytoplasmic tail. It forms oligomers within the virus membrane and is controlling membrane curvature by its conformers [35] . Another abundant structural protein is the nucleocapsid protein N (1000-2000 molecules per particle), which forms complexes with parts of genomic RNA, called ribonucleoparticles (RNPs), with a bead-on-a-string morphology. One virus particle contains around 25 RNPs, some of them are attached to the inner side of the envelope [36] . The most prominent protein of coronaviruses, not in abundance but in terms of protruding from the membrane, is the S protein (around 25 +-10 trimers per particle) that is the sole structural component of the viral spike [37] , is central for receptor recognition, cellular attachment and entry. As this is the central point of infection most attention is focused on blocking the activity of S proteins [38] , which are well visible in Figure 1a . Sixty-six carbohydrates are covalently attached to one S trimer, each carbohydrate chain is composed of 7 to 12 monosaccharides. As a result, most of the surface of S is covered with hydrophilic sugar moieties. The stalk region of the spike contains three flexible hinges, which allows the head domain to bend relative to the membrane to scan the cell surface for putative receptors [39] . Only around 20 copies of the small and hydrophobic E protein are present in the membrane, where they form an ion channel facilitating virus entry. [31] . Similar images can also be seen in ref. [40] . b) Sketch of a SARS-CoV.

Enveloped viruses assemble at and bud from either the plasma membrane or from membranes of the exocytic pathway, which exhibit different lipid compositions. Since a viral capsid is coated with lipids when it buds through the bilayer, it was suggested that the lipid composition of the viral envelope is mostly determined by the host membrane [41] . This has now been most convincingly shown for viruses from four different families that assemble at the plasma membrane. Quantitative mass spectrometry revealed that the lipid composition (~160 lipid species) of Semliki Forest Virus (a togavirus) and Vesicular Stomatitis Virus (a rhabdovirus) are indistinguishable if grown in the same cell type, and only slight differences were detected between the viral lipid composition and that of the plasma membrane [42] .

Viruses supposed to bud through raft-domains, such as influenza viruses and HIV, are slightly enriched in cholesterol and sphingolipids compared to the apical plasma membrane (influenza) or are substantially enriched in the rare sphingolipid dihydrosphingomyelin (HIV) [43, 44] .

For viruses that bud from intracellular membranes, only two sophisticated lipid analyses are available [45, 46] . Strikingly, cholesterol ester, a storage form of cholesterol that is not a component of cellular membranes, is the major component of the envelope of Hepatitis C Virus (HCV), followed by cholesterol, although the virus buds through the ER membrane which is low in cholesterol. The unique lipid composition is a result of the unusual egress pathway of HCV, that coopts very-low-density lipoprotein (VLDL) particles, which are secreted from liver cells to supply the body via the blood stream with lipids [45] . However, cholesterol and sphingolipids are also prominent in the envelope of Bovine Viral Diarrhea Virus (BVDV), another member of the Flaviviridae, and its lipid composition is very similar to that of influenza virus. It was suggested, therefore that BVDV either buds through (hypothetical) ER microdomains already enriched in cholesterol and sphingolipids or recruits these lipids to the budding site [46] .

No detailed lipidomic analysis is available for other viruses that bud through intracellular membranes, but sphingomyelin, a "raft-lipid" is enriched relative to the lipid content of the whole cell in the envelope of both Equine Arteritis Virus, a member of the Arteriviridae that are closely related to Coronaviridae, and mouse hepatitis virus, a coronavirus [47] .

In summary, viruses tend to integrate lipids into their envelope that increase the mechanical stiffness of their membranes. [48] In fact, the lipid composition of enveloped viruses is remarkably similar, even if they derive from different cellular membranes. The main J o u r n a l P r e -p r o o f constituent is always cholesterol (37-52 mol%), followed by phospholipids (30-37%) and

sphingolipids (18-20%) . In contrast to cholesterol and sphingolipids, the content of the individual phospholipid species roughly corresponds to the membrane from which the virus is derived. The main phospholipid in both HCV and BVDV is PC, which is also predominant in the ER membrane, whereas viruses that bud at the plasma membrane contain mainly PS, that is enriched in the plasma membrane relative to the ER [41] [42] [43] [44] [45] [46] [47] . Furthermore, the surface proteins of Dengue virus, that do not form spike-like protrusions but lie flat on the membrane in an icosahedral-like symmetry, interact extensively with the lipids conferring ''raft-like'' robustness even on a cholesterol-poor membrane [49] .

It might be noted that for instance the influenza lipid envelope is softer than expected for a gel phase bilayer and its stiffness changes only rather little with increasing temperature. [50] Certainly also the proteins contained in the lipid envelope play a relevant role in determining the membrane stiffness. For instance, AFM experiments on the lipid envelope of influenza virus showed double the stiffness compared to just the pure phosphatidylcholine liposomes, an effect attributed to the membrane-attached protein components. [51] There are several requirements on the biophysical properties of a viral envelope for optimal transmissibility: The viral pre-envelope must be fluid at body temperature to allow budding of new virus particles. Once the virus is exposed to the environment the membrane should solidify (gel state) to protect virions against damage during transmission between organisms.

After entry into a new host, the viral membrane must liquefy again to allow infection by fusion of its envelope with cellular membranes. It was shown for influenza virus that the temperature profile of its phase transitions roughly fulfils these requirements [52] . Above 42 °C the virus membrane is uniformly liquid, but below 42 °C ordered domains appear that coexist with liquid phases. The fraction of the latter decreases with decreasing temperature until at ~4 °C the whole membrane is solid. The presence of cholesterol was critical for the formation of these phases.

Despite the fact, that the detailed build-up of a virus in terms of molecular components is very complex and normally not fully known for a given virus, its description as a colloidal object may be much too simplified. A very comprehensive review regarding growth, form and properties seen from the physics point of view has recently been given [53] . As a virus must contain highly charged DNA or RNA, compacted by (at least locally) cationic proteins, the J o u r n a l P r e -p r o o f electrostatics in such systems are important and an excellent discussion of the relevant aspects has been given some years ago [54] . However, electrostatics is not only important for understanding the properties of viruses but is also the major driving force for their selfassembly. For instance, the case of equilibrium self-assembly of negatively charged singlestranded (ss) RNA with positively charged capsid proteins has been described based on fundamental physics, which yield assembly equilibria in good agreement with the experimentally observed behaviour [55] . It may be noted that the positive charge of the coredirected tail of the capsid protein does not suffice to neutralize the negative RNA charge, so that even for a rather small capsid the negative core charge may still be in the range of x•1000 e 0 . Accordingly, electrostatics is very important for the interactions of viruses with their surroundings and this issue has been addressed both experimentally (measuring forces by AFM) and theoretically. [56] It should also be noted that the size of a coronavirus and helical nucleo capsids in general increases in lockstep with the length of RNA [57] . Capsids are very well defined structurally, where many viruses have an icosahedral symmetry and are built from a given number of identical subunits. It might be noted here that the icosahedron is the regular polyhedron with the highest volume-to-surface ratio, i.e., optimised for packaging and fast diffusion transport of this packaged payload. The precise shape of polyhedral capsid shells is determined by the proteins it is built from and can be classified elegantly by the Caspar-Klug construction [58] A comprehensive collection of capsid structures determined from cryo-electron microscopy and x-ray crystallography can be found at the VIPER website [59] .

Of course, capsid formation by protein self-assembly is a highly interesting phenomenon in itself. A recent study of capsid growth around an RNA genome followed the growth process by an optical technique and showed that the process proceeds by nucleation and subsequent monotonic growth, and in the case studied 90 chemically identical coat-protein dimers were assembling into a capsid). Both nucleation and growth time decrease with growing protein concentration, but the shortening is much more pronounced for the nucleation time. In any case, the time for complete assembly was around 5-10 mins with concentrations of the coatprotein dimer in the range of 1-5 µM [60] . Accordingly, virus formation is a relatively fast process of complex self-assembly.

Whether these mechanistic steps of the self-assembly processes apply to other, more complicated viruses, remains to be shown. Several viruses, such as influenza and J o u r n a l P r e -p r o o f coronaviruses exhibit a different, helical capsid structure. In the case of influenza virus, the nucleoprotein (NP) oligomerises to form a double-helical hairpin structure, which contains polymerase proteins at one end. The genomic RNA is coiled on the outside of the helical capsid like on a spool [61] . As explained earlier, similar structures, the RNPs are present inside coronaviruses, but their precise structure still needs to be elucidated further.

The interaction of surfactants with viruses has been a topic of investigation for many years, mostly driven by the interest of inactivating viruses by dissolving their lipid envelopes or denaturing proteins essential for their functioning, as the two main mechanisms. With the ongoing COVID-19 pandemic caused by SARS-CoV-2, this topic has suddenly regained highest interest, as it brought into our focus that disabling virus activity can be essential for human survival. In the following, we want to lay out the basic physical chemistry of surfactants and their interaction with viruses, thereby providing the basics for how to use surfactants to suppress virus activity. Based on the fundamental aspects reviewed, we later sketch out directions in which future research activities might be directed to have more specific and efficient use of surfactants in working against the effects of viruses on human and animal health.

As discussed before, enveloped viruses have a variety of positions, where surfactants (they can be subdivided into anionic, cationic, and nonionic surfactants) can bind and interact, in particular the lipid membrane and membrane/envelope proteins. Looking at that aspect from a thermodynamic point of view, the likelihood and effectiveness of binding will depend in general on the affinity of the surfactant for the different binding sites at the virus (see Figure   2 ). In thermodynamics, this affinity is described by the chemical potential µ i of a given species i (here typically the surfactant molecule is relevant). In thermodynamic equilibrium, µ i of the surfactant molecules bound at various places to the virus has to be equal or lower for all positions of binding compared to that of the monomeric surfactant in solution, whose concentration dependence is described by:

(see Figure 2 , a i : activity of species i, for the ideal case being identical to the mole fraction; R:

ideal gas constant, T: temperature, µ 0 i,mon : the standard chemical potential of the monomeric species, typically taken for the case of infinite dilution; its value will depend on the molecular architecture of the surfactant, being more negative for more hydrophobic surfactants, being more positive for more hydrophilic surfactants, accordingly the whole chemical potential curve can be shifted in y-axis by the choice of the surfactant). Accordingly, the reference point that determines whether binding of surfactant takes place or not is naturally set by the concentration of free surfactant in solution. This means that for a surfactant to be effectively interacting with a virus, the chemical potentials of its relevant binding sites have to be sufficiently low so that this binding occurs at the lowest possible concentrations (see Figure 2 , lower plateau for binding to protein). In particular, it should be below that of the micelles that are formed above the cmc (critical micelle concentration), as otherwise any further addition of surfactant would become micellised but not bind directly to the virus (of course, micelles may also interact with viruses, see below). In contrast, the lower the chemical potential of the surfactant at the binding site, the lower the concentration at which the surfactant will be bound thereto potentially inactivate the virus. This means that ideally the affinity of the surfactant to the virus binding sites has to be more pronounced than its tendency for micelle formation (µ i,prot < µ i,mic ).

which surfactant molecules may become incorporated (defined in Figure 2 by µ i,bil ). The driving force will largely be hydrophobic interaction, but potentially also electrostatics may play a role, especially if the surfactant is oppositely charged (cationic). One may expect that at least initially some surfactant may be bound within the lipid bilayer (see Figure 2 ) but its incorporation will raise the chemical potential of the surfactant in the bilayer and one may expect that it becomes thermodynamically instable once a certain percentage of surfactant is contained in the lipid bilayer. Controlling the extent of partitioning of a surfactant into a lipid bilayer is its chemical potential µ i,bil within that bilayer. This can be studied by calorimetric investigations, for instance by isothermal titration calorimetry (ITC), where for SDS an exothermic partition enthalpy of -25 kJ/mol (at 28 °C) for 1-Palmitoyl-2-oleoyl-sn-glycero-3phosphocholine (POPC) bilayers has been reported and this investigation also yielded a SDSmembrane equilibrium constant of 1.2-6•10 4 l/mol for the range of conditions investigated [62] . In contrast, nonionic and zwitterionic surfactants, and free fatty acids have been reported to have endothermic partition enthalpies at room temperature [63] .

For any binding site hydrophobic and electrostatic interactions should play a role. In addition, especially for the interaction with biomolecules, more specific interactions may also play an important role, including short ranged H-bonding (however, it should be noted that under physiological conditions also electrostatic interactions are rather short range, controlled by a Debye screening length of ~0.7 nm), whose strength depends strongly on the match of the molecular architectures, π-interactions, and potentially even forces due to complexation mediated by metal ions. A particular binding site would be the proteins in the outside structure of the virus but given the varied structure of potentially relevant proteins, like M, N, E or S proteins (see 3.1), the binding affinity will depend largely on their detailed structure and state of assembly. Accordingly, the chemical potential µ i,prot of the bound surfactant molecule can vary substantially from the micellised state (µ i,mic ) of the surfactant ( Figure 2 ).

In biochemistry, binding affinity is typically analysed via the Scatchard plot/equation that yields the dissociation or formation (binding) constant (both being the inverse of each other), the number of binding sites, and potentially information regarding the cooperativity of the process. For a process of two components, A and S (surfactant), forming a complex AS the formation constant K is given as:

with µ 0 A , µ 0 S , and µ 0 AS , being the standard chemical potentials of component (binding site) A, surfactant, and formed complex AS, respectively. It becomes clear from this formula that enhancing the standard chemical potential of the surfactant, µ 0 S , for instance by increasing its hydrophobicity by lengthening its alkyl chain, will in turn enhance the binding strength at a given binding site. i,mon + RTlna i (µ 0 i,mon becomes more positive with increasing hydrophobicity of the surfactant, thereby increasing its tendency for binding to sites and lowering the cmc). Also shown are the levels for the chemical potentials of micelles (µ i,mic ), within a lipid bilayer (µ i,bil ) and two different potential binding sites on a virus protein (µ i,prot ).

As an alternative way of interaction, above the cmc, surfactants can solubilise lipids or other molecules essential for the function of the virus within micellar aggregates, i.e., they can induce a leaching out of lipids from the membrane. This is to be expected above the cmc and would likely lead to inactivation of enveloped viruses, but typically also requires relatively high surfactant concentrations, which often one wants to avoid due to general surfactant toxicity.

Accordingly, in order to have surfactants that are efficiently inactivating viruses, either their chemical potential at the binding sites should be as low as possible, which will depend on the specific molecular interactions with either lipid membrane or protein, or one works with surfactants having as low a cmc/critical aggregate concentration (cac) as possible, This can be achieved by rendering the surfactant more hydrophobic and thereby increasing µ 0 i,mon , which, from thermodynamics, is the key parameter to control surfactant activity. The latter is usually directly related to the length of the hydrophobic chain(s) and lower for nonionic than ionic surfactants [64] . However, for straight chains, one typically faces the problem of insolubility.

Accordingly, the solution to achieve a low cmc would be employing branched chains or long chains containing double bonds. A viable alternative are double-chain surfactants, such as typical phospholipids or dialkyl(ester) quats as they are employed in fabric softeners [65] ).

They typically do not form micelles (due to their packing preference; having a cylindrical shape) but above their critical aggregate concentration, vesicles are often present and the cac is normally in the nM to µM range. A further alternative are amphiphilic copolymers of block or graft structure, which generally have very low cmc values [66] . Such polymer surfactants often interact strongly with lipid bilayers and even such highly biocompatible copolymers of the PEO-PPO-PEO (Pluronic ©) type have been shown to disturb lipid bilayers substantially [67] .

For maximizing the binding affinity of a surfactant to virus components, one has to mainly consider that lipid membranes, due to the presence of sialic acid-containing glycolipids, are negatively charged generally and that cationic surfactants are most strongly attracted, which also explains the generally high biotoxicity of cationic surfactants compared to others. As a basic rule, the affinity of a surfactant to become incorporated into a lipid bilayer (quantified by µ i,bil ) will depend largely on the molecular architecture of the surfactant and on the lipid composition of the bilayer. It can be described by a distribution coefficient that gives the probability for being in a bilayer compared to being in the corresponding aqueous solution.

Such distribution coefficients can be measured experimentally, but their determination is not necessarily simple and becomes more challenging if the affinity is very high. The most direct and reliable way to determine the thermodynamics of the surfactant/bilayer interactions is certainly isothermal titration calorimetry (ITC) that not only gives the partition coefficient, but also enthalpy, entropy, and free energy of the transfer process of the surfactant into the bilayer [68] . However, more recently the theoretical calculation of distribution coefficients based on molecular simulations has also been advanced, for instance for describing the sorption data of single-chain and double-chain cationic surfactants. This approach also allows handling of more strongly membrane attracted cationic surfactants [69] .

By comparison, the binding to proteins is much more complex. The binding at different protein sites will have very different effects with respect to inactivation. Binding to some sites J o u r n a l P r e -p r o o f may have no effect at all, while binding at others may effectively disable protein function altogether. This means that smart molecular design requires determination where surfactant should bind at a given protein. For the binding electrostatic and hydrophobic interactions may be most relevant but H-bonding can also be important as can even more specific molecular

interactions. This will largely depend on the molecular details of the protein binding site and, hence, structural features with atomistic resolution will be important as they can be obtained from highly resolved scattering/diffraction experiments and NMR, but also from molecular modelling approaches.

Investigations on the thermodynamics of the interaction of surfactants with viruses are rare. In one notable exception, human influenza (H3N2) and avian influenza virus strains (H5N3)

were investigated with respect to the effect of the surfactants potassium oleate (KOl), SDS, and sodium laureth sulfate (SLES). Interestingly, infectivity was reduced most dramatically by KOl, much less by SDS, and still somewhat less by SLES. A parallel investigation by isothermal titration calorimetry (ITC) for KOl showed a marked exothermic interaction with the H3N2 virus, while it was less exothermic for SDS, and even endothermic for SLES. This was interpreted such that the interaction is dominated by electrostatics in the case of KOl, while for SLES hydrophobic interactions prevail [70] . This investigation nicely shows that fundamental thermodynamic investigations can help in the understanding of the interactions relevant to reducing the infectivity of viruses.

While we discussed the thermodynamics of an equilibrated situation for virus inactivation by surfactants in the previous chapter, the other essential issue is the time scale at which the interaction/binding will take place. This means we must look at the kinetics of surfactantvirus interaction, which determines how fast such an equilibration is achieved.

The main point here is that a surfactant molecule must diffuse to a given binding site of a virus. That process has basically been described by von Smoluchowski more than 100 years ago [71] . Typically, diffusion-controlled reactions are very fast, but for some situations in surfactant-virus interaction this may no longer be the case as the virus concentration is necessarily low. If surfactant concentration is equally low, and for many applications one may target a low cmc, for example for reasons of surfactant toxicity or ecological concerns, the J o u r n a l P r e -p r o o f reaction times may become very long. The mean time τ required for one virus particle of radius R V to be hit by a surfactant molecule can be estimated as:

where c S is the surfactant concentration, D s the diffusion coefficient of the surfactant, and N Av Avogadro's constant. Assuming a surfactant concentration of 0.1 mM, D S of 2*10 -10 m 2 /s (neglecting the movement of the virus as its diffusion coefficient is more than 50 times less that of the surfactant), and a virus radius R V of 50 nm, a characteristic time of ~130 ns can be calculated, which means a surfactant molecule encounters a virus particle every 130 ns. It might be noted here that, naturally, the time required for micelles to encounter a virus will be much longer, by a factor larger than their aggregation number, simply due to the correspondingly lower concentration of micelles. If we now look more quantitatively at the interaction of the surfactant with the lipid envelope, we have to consider that for a radius of 50 nm the virus envelope will contain about 125000 lipid molecules under the assumption that their head group area is approximately 0.5 nm 2 . This in turn means that for substituting just 1% of the lipid molecules by surfactant molecules it would take about 0.15 ms. This is assuming the best-case scenario that every encounter leads to incorporation of surfactant into the bilayer, while, in reality, one may expect here a certain activation energy to be required that would slow down this process substantially. Of course, the time required for a surfactant molecule to encounter a protein by diffusion will be much longer as the protein is much smaller. One may estimate it from eq. 1 by assuming a protein size, where a radius of 2-5 nm is realistic, but in addition the proteins might also be partly protected by being incorporated within a bilayer or a larger protein assembly, so only a part of it is free for contact. Somewhat different is the situation for membrane proteins, as the mobility of surfactants within a bilayer is very high and accordingly, the ease of encountering a membrane protein bound in the membrane. In any case, just being in contact is not enough for a surfactant to bind and interact further, because first, the probability to hit the virus surface at the proper place for binding (e.g., location of a protein, see Figure 1 ) is not necessarily very high; it is certainly much higher for hitting the lipid membrane than for a specific protein. Second, making contact does not mean binding, as there will always be steric effects. For instance, binding of a surfactant molecule to a protein requires the proper orientation at the right position of the protein and an activation energy E a must be exceeded before binding can take place. Both aspects can be accounted for by an effective activation energy E a,eff that is reducing the rate of this binding process by a factor exp(-E a,eff /kT), compared to the probability of just having a collision, which would be the maximum possible rate. This concept applies similarly to the incorporation of surfactant into the lipid bilayer, but this process will be much faster due to the fact that by area the lipid envelope is much bigger and E a,eff should be much lower as the incorporation of a surfactant molecule into an existing bilayer is relatively easy.

Liposomes are vesicles composed of a lipid bilayer, which are often used as model systems 

Besides lipids, proteins are the other major building blocks of biological membranes. In general, surfactants are well known to bind to proteins, the main driving forces being electrostatic, hydrophobic, and H-bonding. Given the large number of structurally different J o u r n a l P r e -p r o o f proteins and surfactants, the topic of surfactant-protein interactions is a very large and fastevolving field, which cannot be covered in further depth here, but was reviewed some time ago [89] . Binding of a surfactant often leads to denaturation of the protein, either by unfolding or by formation of protein-surfactant complexes [90] . Rather well studied has been the binding of fatty acids to proteins, as there is also a particular class of fatty acid binding proteins (FABP), which are involved in fatty acid transport and metabolism. Interestingly fatty acid binding is largely driven by enthalpy, where van't Hoff enthalpies of ~ -40-50 kJ/mol were observed for fatty acids such as oleic acid, arachidonic acid, or palmitic acid, the precise value depending to a certain extent on the origin of the FABP [91] . This is different to typical hydrophobic association, which is driven by entropy [92] . The binding affinity and the corresponding Gibbs free energy of binding, are systematically increasing with increasing hydrophobicity of the fatty acid. This has similarly been observed for the binding of different fatty acids to bovine serum albumin (BSA) for which also binding enthalpies of -50 to -30 kJ/mol were reported, but the process becoming less exothermic with increasing length (hydrophobicity) of the fatty acid [93] . However, as discussed in Chapter 4, not only the thermodynamics of this binding process but also the kinetics are relevant. Here for different fatty acids a kinetic of off-rate constant in the range of 0.5-5 s -1 has been observed at room temperature, actually becoming faster for fatty acids of J o u r n a l P r e -p r o o f increasing chain length [94] , which is a bit counterintuitive. However, in any case these complexes are rather long-lived.

The Copyright 1975 American Chemical Society.

Regarding coronaviruses, especially the S glycoproteins might be a weak point as S damage will lead to a loss of virus infectivity, as was demonstrated for the murine hepatitis coronavirus MHV-A59. [100] It has been reported for SARS-CoV-2 that the receptor binding domains of S tightly bind the fatty acid linoleic acid in three composite binding pockets. This binding apparently reduces virus activity as one observes a synergistic effect and enhanced suppression of SARS-CoV-2 replication, when treatment with the polymerase inhibitor remdesivir is combined with linoleic acid addition [24] In addition, several glycoproteins of enveloped viruses interact with cholesterol within the membrane and this interaction is vital for the function of the protein during virus entry by membrane fusion and virus release by budding [20] [21] [22] . Replacing the natural cholesterol in the virus membrane by other sterols has been shown to affect the rate of membrane fusion and hence might inhibit virus entry. [101] J o u r n a l P r e -p r o o f

The Initial steps of virus replication (virus binding and entry) can also be studied using fluorescence-based methods, such as fluorescence-assisted cell sorting (FACS) and fluorescence microscopy. They are more sensitive, quantifiable and can be scaled up and automated, but require specialized equipment and expertise.

In summary, there is no definitive answer to the seemingly simple question about the number of infectious particles in a virus preparation. It depends on the assay and cell types used.

Methods that quantify viral genome copy number, such as PCR, are not suitable for determining the infectivity of viral particles because neither lipid-nor protein-targeted treatments affect the viral genome, and hence the genome copy number remains the same before and after treatment.

Coronaviruses seem to be remarkably stable on various surfaces. Several studies for SARS,

days on many common hard surfaces, such as steel, glass or plastic, although virus titres dropped significantly during that time [102] . Therefore, disinfection of frequently touched surfaces is key to stopping virus spread. While common disinfectants mainly contain ethanol or isopropanol, it was shown that addition of surfactants increases virucidal efficiency [103] .

The different types of sanitising agents for virus inactivation and disinfection have been reviewed recently, including which types of surfactants are used but also with a large range of other chemical compounds employed in that context [104] . A longer while ago also specifically the inactivation of Coronaviruses has been reviewed [105] .

Due to its importance, the field of disinfecting virus-contaminated surfaces is one that has been investigated thoroughly for a long time, and surfactants traditionally play an important role when it comes to disinfection [106] . A recent review not only describes in a comprehensive fashion the antiviral activity of surfactants but also other health-related functions of surfactants, like antimicrobial activity or anti-oxidative properties [107] , and we have summarised the main existing or developing antiviral applications of surfactants in Table   1 .

In general, the role of surfactants is not just that of interacting with the lipid envelope (and typically dissolving it) or of denaturing proteins. In most practical situations on a dried surface, one may not encounter individual viruses but mainly agglomerates, in which many viruses are lumped together. The function of surfactant then is to dissolve such agglomerates and render the individual viruses accessible, which means that surfactant activity is quite similar to that in one of its principal actions in detergency. Otherwise, the viruses inside of such agglomerates would be rather well protected from any type of inactivation. [106, 108] Accordingly, surfactants can also be very important as an "access facilitator" in formulations with other antiviral components, by allowing them to access individual viruses more easily.

Absolutely classic in the context of disinfection is the use of soap for inactivation of influenza viruses shown to be effective around neutral pH more than 80 years ago [109] , i.e., before even knowing much about virus structure. In addition, conventional anionic detergents like SDS were also shown early on to be similarly effective in reducing the infectivity of tomato bushy stunt and potato X viruses. [110] The rather general activity of SDS against enveloped (for instance HIV) and non-enveloped viruses has already been reviewed some 20 years ago, has been assumed to be due to denaturing lipid envelope and/or capsid proteins, and generally its antiviral activity is already present at not-cytotoxic concentrations [111] . As anionic surfactants are primarily active against enveloped viruses but not against non-enveloped viruses, it can be concluded that they primarily interact with the lipid bilayer [106] , despite the fact that the lipid bilayer itself also has anionic character. In general, it has been observed that enveloped viruses are more sensitive to the interaction with chemical agents, such as surfactants, than non-enveloped viruses [112] . It might also be noted that liquid soaps, e.g.

made from sodium lauryl ether sulfate and cocamidopropyl betaine, are more effective against non-enveloped viruses such as human noroviruses than ethanol-based hand sanitisers, while for the enveloped viruses the opposite behaviour has been observed [113] . This can be explained such that alcohols like ethanol or isopropanol are very effective in dissolving lipid bilayers but have only very little effect on non-enveloped viruses, whereas surfactants work on both types of virus, but are also more effective against enveloped viruses. In that context it should also be noticed that simply distinguishing the antiviral activity with respect to having an enveloped or non-enveloped virus is oversimplifying the situation as different response is also seen for different enveloped viruses and also with respect to employing different surfactants, as for instance demonstrated for cationic compounds. [114] J o u r n a l P r e -p r o o f When looking more specifically at coronaviruses, the activity of the replication/transcription complex of SARS-CoV was greatly reduced by the presence of the nonionic surfactant Triton X-100, indicating that its effect on lipid membranes rendered this complex inactive, thereby inhibiting virus replication [115] . Similarly for SARS-CoV-2, effectiveness of classical, often surfactant-based, disinfectants has been ascertained [116] . Even simple household surfactants like sodium laureth sulfate (commonly found in shampoos) have been shown to inactivate SARS-CoV-2 effectively at low concentrations of 0.1 wt% within 60 s on a large variety of different inanimate surfaces [117] .

In comparison, cationic surfactants are more established bactericidal compounds and quaternary alkyl ammonium (QUAT) compounds are commonly employed for disinfection, e.g. benzalkonium chloride. [118, 119] The antiviral action or didecyldimethylammonium chloride, but also pyridinium, imidazolium or isoquinolium surfactants have been intensely studied in that context [120] [121] [122] [123] .

QUATs are the most widely employed group of disinfectants for hard surfaces. However, even though they are very potent antimicrobial agents, they are generally much less effective in inactivating viruses [124] . This is particularly evident for non-enveloped viruses but still markedly observed for enveloped ones, especially after they have been dried on surfaces.

However, antiviral activity can become enhanced by rendering the systems more acidic by addition of HCl [125] This aspect has been critically discussed [126] and comprehensively reviewed recently [102] . The main reason for the lower effectivity of QUATs may be attributed to the fact that their main effect in antimicrobial activity is to modify cell permeability [102] , an effect much less relevant for inactivating viruses, as the virus lipid envelope is mostly for protection and transport across the bilayer is a property of lesser importance. The particularly low efficacy of cationic surfactants with respect to viruses under dry condition on surfaces may also be attributed to the fact that here, in addition to the interaction with the virus lipid envelope, one has also first to disperse the viruses, like dirt in detergency. However, both, typical surfaces and viruses, will be negatively charged and therefore cationic surfactants will perform rather poorly in dispersing them, similar to their relatively poor performance in typical detergency. Nonetheless, the use of QUATs for disinfection has naturally been increasing substantially during the recent pandemic and has been raising concerns regarding their environmental impact [127] . Certainly, a very important aspect for future developments is having formulations that are effective with respect to their J o u r n a l P r e -p r o o f antiviral properties but at the same time mild with respect to toxic effects, and do not come with the risk of environmental damage, as recently discussed for the case of hand sanitation [128] .

The field of hand sanitation is, of course, a central one in controlling virus spread. Regular hand hygiene is very important [129] but typical hand sanitisers are rather harsh surfactants, as is the case for standard alkaline soaps. Accordingly, their frequent application will lead to compromised skin by removing lipids from the stratum corneum and such damaged skin then may become itself more penetrable to viruses and other damaging particles, and one also increases the risk of hand dermatitis. Therefore, working at pH 5.5 to 7.0, i.e., that of healthy skin, and use of mild surfactants is recommended [130] .

On the side of studying the effectivity of surfactants against virus activity, recent studies have been dedicated to not just using single surfactants but combinations thereof in order to benefit from synergistic interactions, similar as is conventionally done in detergency, where typically anionic surfactants are combined with nonionic surfactant to reduce the cmc while retaining the negative charge required in detergency. This was successfully shown for mixtures of the cationic didecyldimethylammonium chloride (DDeCl) with dodecyloctaglycol (C 12 E 8 ) and

cyclodextrin (CD) [131] . Marked synergism in antiviral activity was reported and a 4-log 10 virus inactivation within 15 min contact time was seen for concentrations around the cmc.

As just discussed many surfactant mixtures are quite effective with respect to their antiviral properties. Accordingly, there is a very large number of commercial products on the market, mostly for the use in hospitals, industrial disinfection or preservation of food, which rely on surfactants and mixtures thereof. A rather comprehensive and regularly updated list can be found on the website of Health Canada [132] .

However, it should be noted that the disinfection of large surface areas requires extensive use of surfactants, which will ultimately end up in the environment. It is therefore necessary to increase the use of sustainable and biodegradable surfactants in this area [133] . Promising compounds here are e.g. surfactin or rhamno-and sophorolipids, which have all shown antiviral activity against various enveloped and non-enveloped viruses [134] [135] [136] . Also saponins, which are plant derived biosurfactants, were shown to possess antiviral activity against many viruses, including coronavirus H-CoV-22E9 [137] . SDS a reducing the infectivity of tomato bushy stunt and potato X viruses [110] disinfection [106,10 7] Triton X-100 n activity of the replication/transcription complex of SARS-CoV was greatly reduced [115] effectiveness of classical, often surfactant-based, disinfectants [116] sodium laureth sulfate a inactivate SARS-CoV-2 effectively [117] quaternary alkyl ammonium salts (QUATs) c Disinfection; most widely employed group of disinfectants for hard surfaces [120] [121] [122] [123] hand sanitation [128] benzalkonium chloride inactivates Coronaviruses [118,11 9] chlorhexidine (typically as salt, e.g. as gluconate or digluconate) c antiviral activity against enveloped viruses, as demonstrated for SARS-CoV-2 [138] Chlorhexidine together with CPyC c effective against SARS-CoV-2 in a variety of different formulations [139] different agents in mouthwashes/dentistry [140] anionic peptide surfactant surfactin a very effective against enveloped viruses but: applicability is limited by cytotoxicity [134,13 5] sophorolipid a/n antiviral activity, e.g., against HIV [136,14 1] rhamnolipids a antiviral activity, e. g., against HSV [142] antiviral activity and additive to mask fabrics [143] saponins c antiviral activity against many viruses, including coronavirus H-CoV-22E9 [137] biosurfactants [144] nonionic surfactants like Tween-80, Span-20 n nanoemulsions or microemulsions effective as antiviral formulations [145] nanoemulsion surfactant mixture of Triton X-100, TBP, CPyC a, n, c inactivation of Ebola virus [120] J o u r n a l P r e -p r o o f A frequently employed disinfectant agent in that field is chlorhexidine (typically in the form of its salts, e.g. as gluconate or digluconate), which is not a proper cationic surfactant but forms aggregates in solution [151] . It is a regular component in many pharmaceutical products (e.g., antiseptic mouthwashes), cosmetics or disinfectants, and shows antiviral activity against enveloped viruses, as demonstrated for SARS-CoV-2, where complete inactivation within 30 s was observed, further enhanced by the presence of molecular iodine [138] . Here an interesting study by neutron diffraction, using a model membrane of PC, has shown that chlorhexidine positions itself at the head group of the phospholipid, suggesting a mode of action where the molecule is bent in half and inserts wedge-like into the lipid matrix, a mode of action that is very similar to that employed by antimicrobial peptides when they interact with bilayers [152] . Chlorhexidine is often employed in combination with CPyC, which has been known for a long time to be a very effective microbial for mouthwash formulation, but recently was also shown to be very effective against SARS-CoV-2 in different formulations [139] . The reduction in virus titer was very high (between approximately 1,000-to 10,000-fold, log 10 [142] . The potential of biosurfactants in the fight against COVID-19 has been reviewed very recently, including options for using them as delivery agents [144] . Rhamnolipids are particularly attractive as they are very mild surfactants that are increasingly employed in cosmetic and personal care formulations, but also have substantial antimicrobial properties [153, 154] . Especially the use of mild surfactants can open up options for employing them in antiviral applications where extended contact times or frequent applications are involved, e.g., mouthwashes, skin lotions, etc., but also in hand washing, since generally surfactants are irritating and therefore total exposure times and concentrations are limited by the irritating or even damaging effect of a given surfactant in such applications. Accordingly, a mild interaction with skin or other body tissue is an attractive feature for surfactants to be applied more generally.

Another type of antiviral surfactant is the anionic peptide surfactant surfactin, which has been shown to be very effective against enveloped viruses and concentrations of 80 µM already result in a reduction of larger than 4.4 log 10 for HSV within 15 mins [135] . However, at the same time, the applicability of surfactin is severely limited by its cytotoxicity. Accordingly, the synthesis and evaluation of surfactin analogues has been done and was shown to be a promising pathway for developing tailor-made peptide surfactants with antiviral properties and reduced hemolytic activity [155] . Furthermore, other biosurfactants like sophorolipid, a glycolipid produced by yeast, have also been proven to show antiviral activity, e.g., against

HIV [141] . Cardiolipin (based on 1,3-bis(sn-3'-phosphatidyl)-sn-glycerol) liposomes act in a more direct way against HIV and can also be employed topically, e.g., intravaginally [156] .

J o u r n a l P r e -p r o o f As discussed above a major application of surfactants is the disinfection of surfaces.

However, they may also be used to impregnate fabrics to inactivate viruses that come in contact with them, which is particularly important if these fabrics are used for personal protection. Recent research has confirmed the antiviral activity of rhamnolipids in that context and they have been advanced as an additive to mask fabrics with the purpose to inactivate enveloped viruses on a time scale of 3-5 min, thereby potentially significantly enhancing the protection provided by face masks [143] . As stated before, the mildness of rhamnolipids renders them attractive, since masks may be carried over extended lengths of time and therefore more aggressive compounds could lead to corresponding dermatological problems.

Of course, there is a variety of other applications in which surfactants can be employed in the combat against viruses. An obvious one is in the formulation of antiviral medications. The normal task of the surfactant here is to function as an aiding compound to deliver the drug cargo to an infected cell or to some other places where antiviral activity is needed. A typical surfactant-based drug delivery system are liposomes, which also have been employed successfully for the delivery of antiviral drugs [157] . However, recently it has been shown in studies with cell lines that cationic liposomes based on 1,2-distearoyl-sn-glycero-3phosphocholine (DSPC) and cholesterol, where the positive charge was introduced by incorporating stearylamine into the lipid bilayer, are quite effective by themselves in blocking entry of enveloped viruses into cells. This study indicated that binding of the stearylamine liposomes to the cell membranes is at the origin of the effect [158] . In a somewhat related study the admixture of polyethyleneimine (PEI) to lecithin liposomes (made from egg phosphatidylcholine) resulted in vesicle formulation (radius: ~ 150 nm), which performed quite well against HSV [159] .

In this context, it might be noted that also more complex surfactant-based systems like nanoemulsions or microemulsions have been shown to be very effective as antiviral formulations, even when rather mild nonionic surfactants like Tween-80 and Span-20 are employed [145] . One reason might be that microemulsions contain a wide range of hydrophilic and hydrophobic components and microenvironments, which may be more effective in interacting with different components of a virus vital for its functioning. For example, inactivation of Ebola virus was achieved after only 20 min of treatment with a nanoemulsion containing disinfectant. Ebola virus is known to be relatively resistant to many types of inactivation and the nanoemulsion treatment provides a mild and effective alternative J o u r n a l P r e -p r o o f [120] . The nanoemulsion used for this purpose contained a surfactant mixture of nonionic Triton X-100, anionic tri-n-butyl phosphate (TBP) and cationic cetylpyridinium chloride (CPyC) [121] . Especially CPyC, which is widely employed in personal care products like mouthwashes, has been advanced recently to be a likely candidate for effectively disabling enveloped viruses, including SARS-CoV-2 [122] , where its effect is speculated to be a combination of destroying the capsid as well as lysosomotropic action [123] .

Last but not least we should also mention that surfactants, particularly in the form of lipids, are essential components of delivery vehicles of many vaccines, which applies especially to mRNA-based formulations [146] , where typically small vesicles are used and both natural and synthetic lipids are employed [147] . However, also for the formulation of other COVID-19

vaccine delivery systems surfactants are widely employed [148] . mRNA needs protection against potential degradation once it is in a biological fluid and therefore typically lipid-based vaccine delivery systems are used, and not only in the case of antiviral vaccines [160] . Here pH-sensitive lipids are interesting for controlling mRNA escape from endosomes and PEGylated lipids are important to impart "stealth" properties to the delivery systems. The structure of such lipid nanoparticles as mRNA delivery systems is essential for understanding their performance and has been studied by many methods. In particular, neutron scattering with its unique contrast options has given detailed insights into the internal structure of such lipid nanoparticles (LNPs). [161, 162] While the topic of vaccine delivery is a very interesting one, it is also a very broad topic in itself, and we, therefore, decided not to cover it here in any further detail. But with the help of the given references the interested reader should be able find his own way.

Finally, surfactant can also be important in the treatment of the COVID-19 diseases. As the disease is mainly affecting the lungs, treatment with lung surfactant can be expected to play an important role in remedying its health effects and potentially contribute to curing the disease. [163] 

So far, we discussed applications in which surfactants are either already used or ready for use.

However, one may well envision that there are still ample further developments of antiviral applications of surfactants possible, not necessarily always in a direct fashion but also in formulations where surfactants play an important role in rendering this formulation more J o u r n a l P r e -p r o o f active by their surface-activity, which typically allows other compound to become dissolved or to allow accessing areas, where antiviral activity is needed, via their wetting properties.

The upper respiratory tract is a major site for virus replication and transmission, especially in the early stages of infection [164] . It is therefore a logical conclusion to try to prevent infection and transmission of the virus with surfactant containing mouthwashes, sprays, oral rinses, gargles, or even toothpaste. Especially the potential role of oral rinses in targeting the lipid envelope of SARS-CoV-2 has been reviewed recently [165] , and certainly there is a lot of development possible, both in the context of the current pandemic, but also with respect to similar future challenges. In a recent study, several commercially available oral rinses were tested for their activity against SARS-CoV-2. It was found that different SARS-CoV-2 variants can be efficiently inactivated with these oral rinses under biologically relevant conditions [166] . It was suggested in earlier studies already that the antiviral activity of Listerine TM is directed to the viral envelope [167] . In that area certainly the use of still milder surfactants might be desirable. One further option for potential application of surfactant as antiviral agents that has been speculated about [168] is intranasal application, but that is a topic still to be explored. Quite related in concept to gargles and mouthwashes, would be the use of antiviral surfactants in toothpaste, chewing gums or drops, which regularly taken, could provide an additional protective measure against becoming infected.

Another application of different surfactants is the impregnation of protective masks or fabrics for inactivating viruses that come into contact with such fabrics in masks or air filters (in air circulating systems), thereby significantly enhancing their degree of protection.

Potentially surfactants could also play a role not just in preventive measures but also as active compounds in new treatment against the respiratory syndrome caused by SARS-CoV-2. A study showed that administration of artificial pulmonary surfactant to mice infected with H1N1 influenza virus in combination with antibody treatment increased the survival rate substantially. The effect was attributed to the surfactant inhibiting alveolar collapse and diffuse alveolar damage in the lungs, thereby preserving lung function for oxygenation. [149] Similarly, phosphatidylglycerol combined with lung surfactant has been advanced for potential treatment of COVID-19 patients, for instance with respect to restoring lung surfactant damaged by infection [150] . However, this is beyond the scope of this review that focuses on the interactions between surfactants and viruses, even if it is of great potential J o u r n a l P r e -p r o o f importance. One may expect that in the treatment of patients that have suffered from an infection with SARS-CoV-2 surfactants will also play an important role.

It is evident that surfactants are already a key player for inhibition of virus infectivity on Tailor-made surfactants may work by specifically binding to a given protein, thereby rendering only selected proteins non-functional. In that instance, the surfactant would then function like a classical and specific drug. However, also in formulations with drugs, which are not surfactants, one may explore increasingly synergistic effects in delivery, arising from enhanced effectiveness and rate of reducing infectivity of viruses. Hence, the role of surfactant will likely be dual by helping with delivery, but also by contributing more directly to the treatment.

In general, one can safely surmise that much more can be expected with respect to the use of surfactants for antiviral applications. More specifically, unraveling the molecular details of their mode of action will certainly become increasingly important as it would allow specific tailoring of their molecular properties to the particular needs, which would result in increased functional efficiency and efficacy. 

Coronaviruses post-SARS: Update on replication and pathogenesis

Soft matter science and the COVID-19 pandemic

Stopping Membrane-Enveloped Viruses with Nanotechnology Strategies: Toward Antiviral Drug Development and Pandemic Preparedness

A comprehensive review regarding the options offered by nanotechnology to battle the effects of virus activity

Antiviral Polymers: Past Approaches and Future Possibilities

Inactivation of avian influenza virus using common detergents and chemicals

Inactivation of feline calicivirus, a Norwalk virus surrogate

Surfactants as Antimicrobials: A Brief Overview of Microbial Interfacial Chemistry and Surfactant Antimicrobial Activity

Functions of lipid rafts in biological membranes

Lipid Rafts: Controversies Resolved, Mysteries Remain

Imaging coexisting fluid domains in biomembrane models coupling curvature and line tension

STED microscopy detects and quantifies liquid phase separation in lipid membranes using a new far-red emitting fluorescent phosphoglycerolipid analogue

Spectrally Resolved, Functional Super-Resolution Microscopy Reveals Nanoscale Compositional Heterogeneity in Live-Cell Membranes

The atomic force microscope as a tool for studying phase separation in lipid membranes (review)

From simple to complex: Investigating the effects of lipid composition and phase on the membrane interactions of biomolecules using in situ atomic force microscopy

Dynamic pattern generation in cell membranes: Current insights into membrane organization

Imaging lipid domains in cell membranes: The advent of super-resolution fluorescence microscopy

Defining raft domains in the plasma membrane

Revitalizing membrane rafts: New tools and insights

A Specific Cholesterol Binding Site Is Established by the 2.8 Å Structure of the Human β2-Adrenergic Receptor

Cholesterol Binding to the Transmembrane Region of a Group 2 Hemagglutinin (HA) of Influenza Virus Is Essential for Virus Replication, Affecting both Virus Assembly and HA Fusion Activity

Ebola virus glycoprotein interacts with cholesterol to enhance membrane fusion and cell entry

Sars-cov-2 requires cholesterol for viral entry and pathological syncytia formation

Identification of a pocket factor that is critical to Zika virus assembly

Together with references 17-19, it is demonstrated that non-covalent binding of lipids (cholesterol or fatty acids) to short amino acid motifs is a common feature of viral glycoproteins. Since binding is functionally important for cell entry and/or assembly of viral particles it is a potential target of surfactants

Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein

This article is very interesting as it discusses the specific interactions of a simple fatty acid with the spike protein of SARS-CoV-2 and how it reduces the effectiveness of this protein in virus infectivity. Such molecularly resolved information of rather simple surfactant molecules with respect to affecting virus activity should become increasingly important for future advanced formulations using surfactants to control virus replication

Lipidomic study of intracellular Singapore grouper iridovirus

How proteins produce cellular membrane curvature

Theory of self-assembly of hydrocarbon amphiphiles into micelles and bilayers

Membrane lipids: Where they are and how they behave

* Classical and easy to read review article that introduces newcomers to the field of cell biology of lipids

Plasma membranes are asymmetric in lipid unsaturation, packing and protein shape

Structures and distributions of SARS-CoV-2 spike proteins on intact virions

Cryo-electron microscopy for the study of virus assembly

Crucial steps in the structure determination of a coronavirus spike glycoprotein using cryo-electron microscopy

SARS-CoV-2 (COVID-19) by the numbers

A structural analysis of M protein in coronavirus assembly and morphology

The coronavirus nucleocapsid is a multifunctional protein

Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges

SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography

Viral envelopes and their relationship to cellular membranes

The Lipidomes of Vesicular Stomatitis Virus, Semliki Forest Virus, and the Host Plasma Membrane Analyzed by Quantitative Shotgun Mass Spectrometry

Quantitative analysis of the lipidomes of the influenza virus envelope and MDCK cell apical membrane

The HIV lipidome: A raft with an unusual composition

* First detailed analysis of the lipid composition of an enveloped virus particle using advanced lipidomics methods

Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome

Morphology and Molecular Composition of Purified Bovine Viral Diarrhea Virus Envelope

The phospholipid composition of enveloped viruses depends on the intracellular membrane through which they bud

How cholesterol stiffens unsaturated lipid membranes

The Role of the Membrane in the Structure and Biophysical Robustness of the Dengue Virion Envelope

Bending and puncturing the influenza lipid envelope

Effect of envelope proteins on the mechanical properties of influenza virus

Progressive ordering with decreasing temperature of the phospholipids of influenza virus

On virus growth and form

An article directly from the "pre-Corona time" that discusses in comprehensive detail the various aspects, how a virus can be seen from the physicists' point, which includes classification of the form, nanomechanics, the growth/assembly process, as well as electrostatics and genome packaging

Energies and pressures in viruses: Contribution of nonspecific electrostatic interactions

Equilibrium self-assembly of small RNA viruses

Quantitative nanoscale electrostatics of viruses

Self-Assembly of Viral Capsid Protein and RNA Molecules of Different Sizes: Requirement for a Specific High Protein/RNA Mass Ratio

*A thorough account of the basic principles that govern self-assembly of viral capsids, an essential aspect of virus replication

Physical principles in the construction of regular viruses

VIPERdb v3. 0: a structure-based data analytics platform for viral capsids n

Measurements of the self-assembly kinetics of individual viral capsids around their RNA genome

The structure of native influenza virion ribonucleoproteins

Thermodynamics of sodium dodecyl sulfate partitioning into lipid membranes

Thermodynamics of fatty acid binding to fatty acidbinding proteins and fatty acid partition between water and membranes measured using the fluorescent probe ADIFAB

Surfactants and interfacial phenomena

Fabric softener technology: A review

Polyisobutylene-block-poly(methacrylic acid) diblock copolymers: Self-assembly in aqueous media

Relationship between the structure of amphiphilic copolymers and their ability to disturb lipid bilayers

Titration calorimetry of surfactant-membrane partitioning and membrane solubilization

Sorption of Cationic Surfactants to Artificial Cell Membranes: Comparing Phospholipid Bilayers with Monolayer Coatings and Molecular Simulations

Inactivation of human and avian influenza viruses by potassium oleate of natural soap component through exothermic interaction

This paper gives sound experimental details on how simple soaps like potassium oleate interact with viruses and thereby are able to disenable their function. More fundamental thermodynamic investigations of this sort will help to clarify further the aspects relevant to suppress virus activity by simple detergents

Versuch einer mathematischen Theorie der Koagulationskinetik kolloider Lösungen

Solubilization of Membranes by Detergents

Classic review article on the use of detergents to extract glycoproteins in functional form from membranes. This allowed viral glycoproteins to be studied by biochemical methods

Self-assembly of mixed ionic and zwitterionic amphiphiles: Associative and dissociative interactions between lamellar phases

DNA-lipid self-assembly: Phase behavior and phase structures of a DNA-surfactant complex mixed with lecithin and water

Liquid crystallinity of lecithin systems. Ternary phase diagrams of lecithin-water with triton X-100 and decanol

A classification of biologic lipids based upon their interaction in aqueous systems

Studies on Mixed Micelles of Triton X-100 and Phosphatidylcholine Using Nuclear Magnetic Resonance Techniques

The interaction of phosphatidylcholine bilayers with Triton X-100

Intermediate structures in the cholatephosphatidylcholine vesicle-micelle transition

*A comprehensive cryo-TEM study of PC vesicles with increasing cholate concentration, visualizing the steps of membrane disintegration described by Helenius and Simons

Solubilization of lecithin vesicles by C12E8. Structural transitions and temperature effects

Mixed micelles and other structures in the solubilization of bilayer lipid membranes by surfactants

*A comprehensive review regarding the effect of surfactant addition on lipid bilayers from the experimentalists point of view

Shape transformation and burst of giant POPC unilamellar liposomes modulated by non-ionic detergent C12E8

Two distinct mechanisms of vesicle-to-micelle and micelle-to-vesicle transition are mediated by the packing parameter of phospholipid-detergent systems

Interactions of surfactants with lipid membranes

**A very thorough and comprehensive review regarding the different relevant aspects of interactions of surfactant with lipid bilayers. A strong focus is on the thermodynamics but also other aspects like kinetics and applications of such interactions are covered

Classifying surfactants with respect to their effect on lipid membrane order

Thermodynamics of antimicrobial lipopeptide binding to membranes: Origins of affinity and selectivity

The mechanism of detergent solubilization of lipid bilayers

Effect of the Electrostatic Charge on the Mechanism Inducing Liposome Solubilization: A Kinetic Study by Synchrotron Radiation SAXS

Protein-surfactant interactions: A tale of many states

Small Angle Neutron Scattering Study of Lysozyme−Sodium Dodecyl Sulfate Aggregates

Fatty acid binding proteins from different tissues show distinct patterns of fatty acid interactions

The hydrophobic effect: Formation of micelles and biological membranes

Albumin binding of long-chain fatty acids: Thermodynamics and kinetics

Thermodynamic and kinetic properties of fatty acid interactions with rat liver fatty acid-binding protein

Lipid Composition of the Viral Envelope of Three Strains of Influenza Virus -Not All Viruses Are Created Equal

The mechanism of detergent solubilization of liposomes and protein-containing membranes

Solubilization of the Semliki Forest Virus Membrane with Sodium Dodecyl Sulfate

*A nice study, following the solubilization of Semliki Forest Virus upon addition of the anionic surfactant SDS by density gradient centrifugation

Chemical Composition of Semiliki Forest Virus

Solubilization of the membrane proteins from Semliki Forest virus with Triton X100

Conformational Change of the Coronavirus Peplomer Glycoprotein at pH 8.0 and 37°C Correlates with Virus Aggregation and Virus-Induced Cell Fusion

Influenza viral membrane fusion is sensitive to sterol concentration but surprisingly robust to sterol chemical identity

Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents

This recent work gives a comprehensive compilation of data available regarding the effectiveness of a larger variety of surfactants and other antiviral agents in disinfection with respect to coronaviruses

Synergistic effects of anionic surfactants on coronavirus (SARS-CoV-2) virucidal efficiency of sanitizing fluids to fight COVID-19

Sanitizing agents for virus inactivation and disinfection

Environmental survival and microbicide inactivation of coronaviruses

Chemical Disinfection of Virus-Contaminated Surfaces

classical review on chemical disinfection of surfaces with a marked focus on eliminating virus activity. Despite its age this review with its very comprehensive discussion the various relevant parameters and aspects is very suitable to gain a general insight into the field of surface disinfection

Surface active agents and their health-promoting properties: Molecules of multifunctional significance

*A very recent and comprehensive review regarding the use of surfactants for promoting the health state of humans with a focus on the microbial and antiviral properties of surfactants. A particular focus is given on newer developments in the field and the increasing use for biosurfactants in it

Molecular Mechanisms of Viral Inactivation by Water Disinfectants

The inactivation of the virus of epidemic influenza by soaps

Liquid Crystalline Preparations of Potoato Virus "X

Sodium Lauryl Sulfate, a Microbicide Effective Against Enveloped and Nonenveloped Viruses

Human Coronaviruses: Insights into Environmental Resistance and Its Influence on the Development of New Antiseptic Strategies

Effectiveness of liquid soap and hand sanitizer against Norwalk virus on contaminated hands

The action of three antiseptics/disinfectants against enveloped and nonenveloped viruses

SARS-coronavirus replication/transcription complexes are membrane-protected and need a host factor for activity in vitro

Stability of SARS-CoV-2 in different environmental conditions

Rapid SARS-CoV-2 inactivation by commonly available chemicals on inanimate surfaces

Virucidal efficacy of physico-chemical treatments against coronaviruses and parvoviruses of laboratory animals

Action of disinfectants on canine coronavirus replication in vitro

Inactivation of Ebola virus with a surfactant nanoemulsion

Antimicrobial nanoemulsion compositions and methods. Patent US20090143476A1

Contact Times, and Use Settings for EPA's List of Products Effective against SARS-CoV-2, the Cause of COVID-19 n

Repurposing Quaternary Ammonium Compounds as Potential Treatments for COVID-19

Chemical disinfection of human rotaviruses: Efficacy of commercially-available products in suspension tests

Chemical disinfection of non-porous inanimate surfaces experimentally contaminated with four human pathogenic viruses

Are Quaternary Ammonium Compounds, the Workhorse Disinfectants, Effective against Severe Acute Respiratory Syndrome-Coronavirus-2?

Increased Use of Quaternary Ammonium Compounds during the SARS-CoV-2 Pandemic and Beyond: Consideration of Environmental Implications

Hand Sanitizer in a Pandemic: Wrong Formulations in the Wrong Hands

Behavioral considerations and impact on personal protective equipment use: Early lessons from the coronavirus (COVID-19) pandemic

Hand hygiene during COVID-19: Recommendations from the American Contact Dermatitis Society

How to improve the chemical disinfection of contaminated surfaces by viruses, bacteria and fungus

COVID-19): List of disinfectants with evidence for use against COVID-19 n

Biosurfactants: A Covid-19 Perspective

Surfactin Inhibits Membrane Fusion during Invasion of Epithelial Cells by Enveloped Viruses

Mechanism of inactivation of enveloped viruses by the biosurfactant surfactin from Bacillus subtilis

Biological activity of sophorolipids and their possible use as antiviral agents

Antiviral effects of saikosaponins on human coronavirus 229E in vitro

Comparative Analysis of Antiviral Efficacy of Four Different Mouthwashes against Severe Acute Respiratory Syndrome Coronavirus 2: An In Vitro Study

Interesting article regarding a potentially important application of surfactants against virus activity by using mouthwashes/gargles. This application could open up to interesting future formulations in the field

Virucidal activity of oral care products against SARS-CoV-2 in vitro. J Oral and Maxillofac Surg Med Pathol 2021

Use of mouthwashes against COVID-19 in dentistry

Sophorolipids, microbial glycolipids with anti-human immunodeficiency virus and sperm-immobilizing activities

Anti-herpesvirus activities of Pseudomonas sp. S-17 rhamnolipid and its complex with alginate

Characterization of Rhamnolipids for the Inactivation of Enveloped Viruses

*A study that shows how cationic and nonionic surfactant, together with cyclodextrine, can work synergistically as disinfectant

Biosurfactants' potential role in combating covid-19 and similar future microbial threats

Antimicrobial activity of biocompatible microemulsions against Aspergillus niger and herpes simplex virus type 2

mRNA vaccine delivery using lipid nanoparticles

Nanomaterial delivery systems for mRNA vaccines

Non-viral COVID-19 vaccine delivery systems

Laninamivir octanoate and artificial surfactant combination therapy significantly increases survival of mice infected with Lethal influenza H1N1 virus

Phosphatidylglycerol and surfactant: A potential treatment for COVID-19?

The colloidal properties of chlorhexidine and its interaction with some macromolecules

Location of chlorhexidine in DMPC model membranes: A neutron diffraction study

Natural surfactants used in cosmetics: Glycolipids

Microbial biosurfactants in cosmetic and personal skincare pharmaceutical formulations

Synthetic surfactin analogues have improved anti-PEDV properties

Liposomes for HIV prophylaxis

Acyclovir-containing liposomes for potential ocular delivery Corneal penetration and absorption

Effects of cationic liposomes with stearylamine against virus infection

Polyethylenimine combined with liposomes and with decreased numbers of primary amine residues strongly enhanced therapeutic antiviral efficiency against herpes simplex virus type 2 in a mouse model

Lipid-based mRNA vaccine delivery systems

Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles

Functionalized lipid nanoparticles for subcutaneous administration of mRNA to achieve systemic exposures of a therapeutic protein

The COVID-19 pandemic: a target for surfactant therapy?

Virological assessment of hospitalized patients with COVID-2019

Potential Role of Oral Rinses Targeting the Viral Lipid Envelope in SARS-CoV-2 Infection

Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2

The antiviral spectrum of Listerine antiseptic. Oral Surg Oral Med Oral Pathol Oral Radiol Endod

Intranasal Antiviral Drug Delivery and Coronavirus Disease 2019 (COVID-19): A State of the Art Review